TET2 and angioimmunoblastic T-cell lymphoma: Based on the transcriptional profiles, AITL is a highly aggressive form of PTCL driven by malignant cells derived from follicular helper T (Tfh) cells, and TET2 mutations are more common in a subgroup of PTCL-NOS displaying Tfh-like features.